However, mutations in MAP2K1, coding for MEK1, a downstream protein of the RAF‐MEK‐ERK‐pathway are seen in half of HCL‐v, suggesting a pathophysiological similarity to HCL‐c mutations [3]. The gene discussed is MAP2K1; the disease is hairy cell leukemia.